Patents by Inventor James S. Fleming, Jr.

James S. Fleming, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions of anagrelide and sulfinpyrazone
    Patent number: 4444777
    Abstract: Supra-additive blood platelet antiaggregation activity is observed with anagrelide in combination with those non-steroidal anti-inflammatory agents which are inhibitors of platelet cyclooxygenase. The supra-additive effects of such combinations make possible new compositions and methods for both therapeutic and prophylactic treatment of thrombosis and other disorders associated with blood platelet aggregation.
    Type: Grant
    Filed: August 5, 1983
    Date of Patent: April 24, 1984
    Assignee: Bristol-Myers Company
    Inventors: James S. Fleming, Jr., Joseph P. Buyniski
  • Pharmaceutical compositions
    Patent number: 4432980
    Abstract: Supra-additive blood platelet antiaggregation activity is observed with anagrelide in combination with those non-steroidal anti-inflammatory agents which are inhibitors of platelet cyclooxygenase. The supra-additive effects of such combinations make possible new compositions and methods for both therapeutic and prophylactic treatment of thrombosis and other disorders associated with blood platelet aggregation.
    Type: Grant
    Filed: August 19, 1982
    Date of Patent: February 21, 1984
    Assignee: Bristol-Myers Company
    Inventors: James S. Fleming, Jr., Joseph P. Buyniski
  • Pharmaceutical compositions
    Patent number: 4357330
    Abstract: Supra-additive blood platelet antiaggregation activity is observed with anagrelide in combination with those non-steroidal anti-inflammatory agents which are inhibitors of platelet cyclooxygenase. The supra-additive effects of such combinations make possible new compositions and methods for both therapeutic and prophylactic treatment of thrombosis and other disorders associated with blood platelet aggregation.
    Type: Grant
    Filed: July 30, 1981
    Date of Patent: November 2, 1982
    Assignee: Bristol-Myers Company
    Inventors: James S. Fleming, Jr., Joseph P. Buyniski